Cardiotoxic effects of anthracycline–taxane combinations

Author： Perotti Antonella   Cresta Sara   Grasselli Giacomo   Capri Giuseppe   Minotti Giorgio   Gianni Luca  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.2, Iss.1, 2003-01, pp. : 59-71

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiotoxic potential and CNS effects of first-generation antihistamines

By Taglialatela M.M.   Timmerman H.H.   Annunziato L.L.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 2, 2000-02 ,pp. : 52-56

Elsevier

Access to resources Recommend Favorite

Effects of chemical combinations in cancer bioassays

By Gough M.  

Regulatory Toxicology and Pharmacology, Vol. 38, Iss. 1, 2003-08 ,pp. : 107-108

Elsevier

Access to resources Recommend Favorite

Erratum: Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone

By  

Cancer, Vol. 121, Iss. 17, 2015-09 ,pp. : 3048-3048

Blackwell Publishing

Access to resources Recommend Favorite

Cardiovascular effects of verapamil enantiomer combinations in conscious dogs

By Pagel P.S.   Hettrick D.A.   Lowe D.   Gowrie P.W.   Kersten J.R.   Bosnjak Z.J.   Warltier D.C.  

European Journal of Pharmacology, Vol. 348, Iss. 2, 1998-05 ,pp. : 213-221

Elsevier

Access to resources Recommend Favorite

Intestinal Drug Absorption Enhancers: Synergistic Effects of Combinations

By Enslin Gill   Hamman Josias   Kotze Awie  

Drug Development and Industrial Pharmacy, Vol. 34, Iss. 12, 2008-12 ,pp. : 1343-1349

Informa Healthcare

Access to resources Recommend Favorite